J Prendiville - Concepedia

Author

J Prendiville

Also Known As

J Prendiville, J. A. Prendiville, J. PRENDIVILLE, J. Prendiville, J.A. Prendiville, Joseph A Prendiville, Joseph Prendiville

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

The Christie Hospital Royal Marsden Hospital Cancer Research UK Manchester Institute St Mary's Hospital The Christie NHS Foundation Trust

About

J Prendiville is an author at The Christie Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	959
2	Health Sciences	4	4	120
3	Public Health	1	1	27
4	Allergy	1	1	14
5	Cell Biology	1	1	11

J Prendiville

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. IE Smith, G. Walsh, Alison Jones, Journal of Clinical Oncology	1995	180
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer Luis Paz‐Ares, Helen J. Ross, Mary O’Brien, British Journal of Cancer	2008	167
A phase I study of intravenous bryostatin 1 in patients with advanced cancer J Prendiville, D. Crowther, Nicholas Thatcher, British Journal of Cancer Advanced CancerMedicineCancer ManagementPharmacologyPathology	1993	144
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma Duncan I. Jodrell, T.R. Jeffry Evans, William P. Steward, European Journal of Cancer Esophageal CancerGastrointestinal OncologyMedicineGastro-oesophageal AdenocarcinomaGastroenterology	2004	129
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer Paul J. Ross, A. Norman, David Cunningham, Annals of Oncology Surgical OncologyMitomycin CMedicineColorectal CancerSurgery	1997	128
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion D Crowther, J Prendiville, AT McGown, British Journal of Cancer Hour Intravenous InfusionMedicinePharmacologyImmune Checkpoint InhibitorPharmacotherapy	1995	124
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer Siow Ming Lee, L. E. James, W. Qian, Thorax	2008	65
A Brief Report on the Safety Study of Induction Chemotherapy Followed by Synchronous Radiotherapy and Cetuximab in Stage III Non-small Cell Lung Cancer (NSCLC): SCRATCH Study Simon Hughes, Janet Liong, Aisha Miah, Journal of Thoracic Oncology Radiation TherapyMedicineBrief ReportSafety StudyScratch Study	2008	64
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer—A phase I toxicity study and pharmacokinetic analysis J Prendiville, Nicholas Thatcher, Michael Lind, European Journal of Cancer Pharmacokinetic AnalysisMedicineImmunologyRecombinant Human Interleukin-4Immune Checkpoint Inhibitor	1993	49
Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma. Howard Gurney, D. Crowther, H. Anderson, PubMed	1990	43

Page 1